Abstract
Preliminary results obtained in mice, rats and piglets experimentally infected with Cryptosporidium sp have indicated a partial prophylactic or curative efficacy of nitazoxanide when administered between 50 and 250 mg/kg BW. In this study, the efficacy of nitazoxanide was evaluated in goat neonates experimentally infected with Cryptosporidium sp oocysts. Forty-seven 2- to 4-day-old kids were experimentally infected once on day 0 with 106 Cryptosporidium oocysts isolated from a dead kid, and allocated to three groups. Group 1 acted as control untreated group, group 2 received nitazoxanide for 8 days from day -1 to day 6 at a daily dose rate of 200 mg/kg BW, group 3 received nitazoxanide for 7 days from day 2 to day 8 at 100 mg/kg BW. Individual oocyst shedding was monitored by daily examination of faecal smears stained by carbol fuchsin and scored semi-quantitatively (zero to four). The other criteria included for nitazoxanide evaluation were weight gain and mortality. In the control group, oocyst shedding that started 3 days post-inoculation (PI) was maximal 6–7 days PI (mean scores ranging from 1.69 to 1.94) and became undetectable from day 16 PI. In group 2, oocyst shedding started 1 day later, peaked 9–11 days PI (1.33 to 1.5) and vanished day 18 PI. In group 3, results were similar to those of group 1 except for the mean scores ranging from 1.0 to 1.58. No significant difference was seen for weight gains between groups. Five kids died in group 1 as well as in group 3, whereas seven kids died in group 2. An acute toxicity of nitazoxanide was suspected as soon as the first 2 days of treatment.
References
Baishanbo A, Gargala G, Duclos C, François A, Rossignol JF, Ballet JJ, Favennec LJ (2006) Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model. J Antimicrob Chemother 57:353–355
Blagburn BL, Drain KL, Land TM, Kinard RG, Moore PH, Lindsay DS, Patrick DA, Boykin DW, Tidwell RR (1998) Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model. Antimicrob Agents Chemother 42:2877–2882
Bleul U, Schwantag S, Stocker H, Corboz L, Grimm F, Engels M, Borel N, Lutz H, Schönmann M, Kähn W (2006) Floppy kid syndrome caused by D-lactic acidosis in goat kids. J Vet Intern Med 20:1003–1008
Bobak DA (2006) Use of nitazoxanide for gastrointestinal tract infections: treatment of protozoan parasitic infection and beyond. Curr Infect Dis Rep 8:91–95
Castro-Hermida JA, Gonzalez-Losada Y, Freire-Santos F, Mezo-Menendez M, Ares-Mazas E (2001) Evaluation of β-cyclodextrin against natural infections of cryptosporidiosis in calves. Vet Parasitol 101:85–89
Castro-Hermida JA, Pors I, Otero-Espinar F, Luzardo-Alvarez A, Ares-Mazas E, Chartier C (2004) Efficacy of α-cyclodextrin against experimental cryptosporidiosis in neonatal goats. Vet Parasitol 120:35–41
Chartier C, Mallereau MP, Naciri M (1996) Prophylaxis using paromomycin of natural cryptosporidial infection in neonatal kids. Prev Vet Med 25:357–361
Chartier C, Mallereau MP, Lenfant D (1999) Efficacité du lactate d’halofuginone dans la prévention de la cryptosporidiose chez le chevreau nouveau-né. Rev Méd Vét 150:341–346
Delafosse A, Castro-Hermida JA, Baudry C, Ares-Mazas E, Chartier C (2006) Herd-level risk factors for Cryptosporidium infection in dairy-goat kids in western France. Prev Vet Med 77:109–121
de Graaf DC, Vanopdenbosch E, Ortega-Mora LM, Abbassi H, Peeters JE (1999) A review of the importance of cryptosporidiosis in farm animals. Int J Parasitol 29:1269–1287
Heine J (1982) Eine einfache Nachweismethode für Kryptosporidien im Kot. Zentralbl Veterinaermed Reihe B 29:324–327
Hemphill A, Mueller J, Esposito M (2006) Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin Pharmacother 7:953–964
Li X, Brasseur P, Agnamey P, Leméteil D, Favennec L, Ballet JJ, Rossignol JF (2003) Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model. Folia Parasitol (Praha) 50:19–22
Lorenzo MJ, Ares-Mazas ME, Villacorta I, Duran D (1993) Effect of ultraviolet disinfection of drinking water on the viability of Cryptosporidium parvum oocysts. J Parasitol 79:67–70
Mancassola R, Repérant JM, Naciri M, Chartier C (1995) Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study. Antimicrob Agents Chemother 39:75–78
Murphy JR, Friedmann JC (1985) Pre-clinical toxicology of nitazoxanide, a new antiparasitic agent. J Appl Toxicol 5:49–52
Naciri M, Yvoré P, Levieux D (1984) Cryptosporidiose expérimentale du chevreau. Influence de la prise du colostrum. Essais de traitements. In: Yvoré P, Perrin G (eds) Les maladies de la chèvre. INRA Publications, Les colloques de l’INRA, n° 28, Niort, France, 9–11 October, INRA, Paris, pp 465–471
Theodos CM, Griffiths JK, D’Onfro J, Fairfield A, Tzipori S (1998) Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob Agents Chemother 42:1959–1965
Villacorta I, Peeters JE, Vanopdenbosh E, Ares-Mazás E, Theys H (1991) Efficacy of halofuginone lactate against Cryptosporidium parvum in calves. Antimicrob Agents Chemother 35:283–287
Yvoré P, Esnault A, Naciri M, Leclerc C, Bind JL, Contrepois M, Levieux D, Laporte J (1984) Enquête épidémiologique sur les diarrhées néonatales des chevreaux dans les élevages de Touraine. In: Yvoré P, Perrin G (eds) Les maladies de la chèvre. INRA Publications, Les colloques de l’INRA, n° 28, Niort, France, 9–11 October, INRA, Paris, pp 437–442
Acknowledgements
We are grateful to IDEXX Laboratories (Dr. Dorsey Kordick) for providing Navigator®.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Viel, H., Rocques, H., Martin, J. et al. Efficacy of nitazoxanide against experimental cryptosporidiosis in goat neonates. Parasitol Res 102, 163–166 (2007). https://doi.org/10.1007/s00436-007-0744-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-007-0744-z